Total planned funding: $254,626,816
Allocations
Countries/Regions
Eswatini | $254,626,816 |
Organizational Types
Private Contractor | $69,268,600 |
University | $52,953,489 |
Unknown | $42,726,459 |
NGO | $37,215,261 |
Own Agency | $32,834,575 |
Host Country Government Agency | $8,272,150 |
FBO | $5,360,534 |
Multi-lateral Agency | $3,855,650 |
Other USG Agency | $1,523,267 |
Implementing Agency | $616,831 |
Program Areas
Treatment | $81,304,846 |
Care | $70,916,571 |
Prevention | $44,337,261 |
Governance and Systems | $26,142,151 |
Management and Operations | $19,680,504 |
Testing | $12,245,483 |
Budget Codes
HTXS: Treatment: Adult Treatment | $63,967,419 |
HKID: Care: Orphans and Vulnerable Children | $27,633,442 |
HBHC: Care: Adult Care and Support | $25,073,580 |
HVMS: Management and Operations | $19,680,504 |
HVOP: Sexual Prevention: Other Sexual Prevention | $18,925,096 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $14,334,761 |
HVCT: Testing: HIV Testing and Counseling | $12,245,483 |
HVTB: Care: TB/HIV | $11,858,888 |
OHSS: Health Systems Strengthening | $10,862,134 |
HVSI: Strategic Information | $10,737,928 |
HTXD: Treatment: ARV Drugs | $9,576,014 |
PDTX: Treatment: Pediatric Treatment | $7,761,413 |
PDCS: Care: Pediatric Care and Support | $6,350,661 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,315,014 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $4,827,390 |
HLAB: Laboratory Infrastructure | $4,542,089 |
HMBL: Biomedical Prevention: Blood Safety | $935,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Columbia University:
$46,551,950
Countries/Regions
Pact, Inc.:
$30,017,874
Countries/Regions
Not Available:
$28,815,579
Countries/Regions
USG Aggregated Agencies:
$17,545,860
Countries/Regions